Avantax Advisory Services Inc. increased its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 24.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,166 shares of the company's stock after acquiring an additional 6,621 shares during the quarter. Avantax Advisory Services Inc.'s holdings in American Healthcare REIT were worth $1,035,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the business. AE Wealth Management LLC boosted its stake in shares of American Healthcare REIT by 7.3% during the first quarter. AE Wealth Management LLC now owns 21,356 shares of the company's stock valued at $647,000 after acquiring an additional 1,455 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in American Healthcare REIT in the first quarter valued at $13,384,000. Y Intercept Hong Kong Ltd bought a new position in shares of American Healthcare REIT in the first quarter worth $401,000. Choreo LLC bought a new position in shares of American Healthcare REIT in the first quarter valued at approximately $354,000. Finally, Allianz Asset Management GmbH acquired a new stake in American Healthcare REIT in the 1st quarter valued at about $2,687,000. 16.68% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, CIO Stefan K.L. Oh sold 3,860 shares of the business's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the transaction, the executive owned 95,671 shares of the company's stock, valued at $3,453,723.10. The trade was a 3.88% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.92% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on AHR. Baird R W raised American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. KeyCorp lifted their price target on shares of American Healthcare REIT from $34.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, June 11th. Morgan Stanley raised their price objective on shares of American Healthcare REIT from $37.00 to $45.00 and gave the company an "overweight" rating in a research report on Tuesday, May 20th. Jefferies Financial Group started coverage on shares of American Healthcare REIT in a research note on Monday, April 28th. They issued a "buy" rating and a $37.00 target price on the stock. Finally, Scotiabank began coverage on shares of American Healthcare REIT in a research note on Monday, June 30th. They set a "sector outperform" rating and a $42.00 price objective on the stock. Ten equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $38.11.
Read Our Latest Stock Analysis on American Healthcare REIT
American Healthcare REIT Stock Performance
American Healthcare REIT stock traded up $0.83 during mid-day trading on Monday, reaching $39.72. 1,619,200 shares of the stock traded hands, compared to its average volume of 1,639,032. The company has a debt-to-equity ratio of 0.45, a current ratio of 0.38 and a quick ratio of 0.38. The stock has a market capitalization of $6.33 billion, a PE ratio of -147.10, a price-to-earnings-growth ratio of 2.18 and a beta of 1.08. The business's 50-day moving average is $36.35 and its 200-day moving average is $32.31. American Healthcare REIT, Inc. has a 12-month low of $14.79 and a 12-month high of $39.89.
American Healthcare REIT (NYSE:AHR - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. American Healthcare REIT had a negative return on equity of 1.85% and a negative net margin of 1.96%. The firm had revenue of $540.60 million during the quarter, compared to analysts' expectations of $542.32 million. During the same quarter last year, the business posted $0.30 earnings per share. The firm's revenue was up 8.2% on a year-over-year basis. As a group, sell-side analysts predict that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.
American Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, June 30th. American Healthcare REIT's dividend payout ratio (DPR) is currently -370.37%.
About American Healthcare REIT
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Recommended Stories

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.